HOECHST MARION ROUSSEL INC
SC 13G/A, 1996-02-13
PHARMACEUTICAL PREPARATIONS
Previous: HOECHST MARION ROUSSEL INC, SC 13G/A, 1996-02-13
Next: MARSH & MCLENNAN COMPANIES INC, SC 13G/A, 1996-02-13



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                 SCHEDULE 13G/A
                                        
                   Under the Securities Exchange Act of 1934
                                        
                               (Amendment No. 3)



                                  GENSIA, INC.
                          ----------------------------
                                (Name of Issuer)


                     Common Stock par value $.01 per share
- ---------------------------------------------------------------------------
                         (Title of Class of Securities)


                                  372450 10 6
                               -----------------
                                 (CUSIP Number)


                               William K. Hoskins
                                General Counsel
                          Hoechst Marion Roussel, Inc.
                            10236 Marion Park Drive
                                 P. O. Box 9627
                           Kansas City, MO 64134-0627
                                 (816) 966-5000
- ---------------------------------------------------------------------------
                 (Name, Address and Telephone Number of Person
               Authorized to Receive Notices and Communications)
















Check the following box if a fee is being paid with this statement [  ].


                                  Page 1 of 4

                           There is no Exhibit Index

<PAGE>                                                                2
CUSIP No.  372450 10 6
___________________________________________________________________________

1)   Name of Reporting Person and its         Hoechst Marion Roussel, Inc.
     I.R.S. Identification Number             44-0565557
___________________________________________________________________________

2)   Check the Appropriate Box if                                  (a)[   ]
     a Member of a Group                                           (b)[ x ]
___________________________________________________________________________

3)   SEC Use Only
___________________________________________________________________________

4)   Citizenship or Place of Organization                         Delaware
___________________________________________________________________________
     
               5)   Sole Voting Power                            3,396,442
Number of      ____________________________________________________________
Shares
Beneficially   6)   Shared Voting Power                                  0
Owned by       ____________________________________________________________
Each
Reporting      7)   Sole Dispositive Power                       3,396,442
Person With    ____________________________________________________________

               8)   Shared Dispositive Power                             0
___________________________________________________________________________

 9)  Aggregate Amount Beneficially Owned                         3,396,442
     by Each Reporting Person
___________________________________________________________________________

10)  Check Box If the Aggregate Amount                                 [  ]
     in Row (9) Excludes Certain Shares
___________________________________________________________________________

11)  Percent of Class Represented                                    12.2%
     by Amount in Row (9)
___________________________________________________________________________

12)  Type of Reporting Person                                            CO
___________________________________________________________________________
















<PAGE>                                                                3

     This Amendment No. 3 amends the Statement on Schedule 13G (the
"Schedule 13G") of Hoechst Marion Roussel, Inc. (formerly Marion Merrell
Dow Inc.) ("HMRI") dated February 11, 1992, as amended through the date
hereof.  This amendment is filed solely to report a change of ownership of
the outstanding stock of HMRI.  Dow Chemical Company ("Dow") no longer owns
a majority interest of the outstanding common stock of HMRI.  88.5% of the
outstanding common stock is now owned by Hoechst Corporation, a wholly
owned subsidiary of Hoechst Aktiengesellschaft, a German corporation
("Hoechst AG"), and the balance by various other subsidiaries of Hoechst
AG.  HMRI is the owner of the securities to which this Statement relates,
with respect to which HMRI (as Marion Merrell Dow Inc.) has filed a
Statement on Schedule 13G.

Item 2(a).  Name of Person Filing.
- ----------  ----------------------

Item 2(a) of this Schedule 13G is hereby amended to read as follows:

     Hoechst Marion Roussel, Inc.

Item 2(b).  Address of Principal Business Office.
- ----------  -------------------------------------

Item 2(b) of this Schedule 13G is hereby amended to read as follows:

     10236 Marion Park Drive, Kansas City, Missouri 64137-1405
































<PAGE>                                                                4
                                   SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.

                                        HOECHST MARION ROUSSEL, INC.



Date:  February 12, 1996                By:  /s/ William K. Hoskins       
                                             -----------------------       
                                        Name:  William K. Hoskins
                                        Title: Vice President, General
                                               Counsel and Corporate
                                               Secretary



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission